endometrial cancer

Endometrial cancer

Endometrial cancer is a type of uterine cancer that originates in the endometrium – the lining of the uterus.1

Endometrial cancer is the most common type of uterine cancer, accounting for ≥90% of cases, with rarer types such as uterine sarcomas (arising from the muscle or connective tissue of the uterus) and other non-endometrial types accounting for the remainder of cases.2 Endometrial cancer is the fourth most common cancer in women in the UK.3,4
Although 1 in 39 women in the UK will develop endometrial cancer in their lifetime, it is estimated that 34% of cases are preventable.3

Learn more about endometrial cancer:

doctor explaining diagnosis to patient

Disease overview

Epidemiology, diagnosis, risk factors, FIGO staging, prognosis & recurrence

LEARN MORE

laboratory testing

Biomarker testing

Biomarker testing is crucial to assess prognosis, inform therapy decisions and predict treatment response

LEARN MORE

doctor explaining treatment to patient

Treatment landscape

Evidence-based management of endometrial cancer

LEARN MORE

References (all URLs accessed May 2026)

  1. Cancer Research UK. Types and grades of womb cancer. https://www.cancerresearchuk.org/about-cancer/womb-cancer/stages-types-grades/types-grades;
  2. Cancer Research UK. Uterine cancer incidence statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence;
  3. Cancer Research UK. Uterine cancer statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer.
  4. The Royal Marden Hospital. Gynaecological cancers women need to be aware of. https://www.royalmarsden.nhs.uk/private-care/news-and-blogs/gynaecological-cancers-women-need-be-aware.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com

©2024 GSK group of companies GSK group of companies. All rights reserved.

NX-GB-DST-WCNT-260001 | May 2026 (V1.0)